Conference Code: 17UK09ICVH
Conference Aims and Objectives
The ICVH 2017: 19th International Conference on Viral Hepatitis
aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Viral Hepatitis. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Viral Hepatitis.
Call for Contributions
All honorable authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Viral Hepatitis are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.WASET
Federated conference series is an event that brings together significant number of recurring events; academic conferences, symposia, workshops, special sessions, and plenary talks in the field of science and technology since inception in 1999. Each event may run over any span of time within the conference days.
All submitted conference papers will be blind peer reviewed by three competent reviewers. The peer-reviewed conference proceedings are indexed in the International Science Index (ISI)
, Google Scholar
, Semantic Scholar
, and other index databases. The conference abstracts and proceedings book, CD and certificate of presentation will be distributed to participants at the conference registration desk. Impact Factor Indicators
Special Journal Issues
has teamed up with the Special Journal Issue on Viral Hepatitis
A number of selected high-impact full text papers will also be considered for the special journal issues. All submitted papers will have the opportunity to be considered for this Special Journal Issue. The paper selection will be carried out during the peer review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly. Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor. To participate as a sponsor or exhibitor, please download and complete the Conference Sponsorship Request Form
|Abstracts/Full-Text Paper Submission Deadline
||July 31, 2017
|Notification of Acceptance/Rejection
||August 14, 2017
|Final Paper (Camera Ready) Submission & Early Bird Registration Deadline
||August 21, 2017
||September 21 - 22, 2017
Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers. Downloadable versions of the check list for
Please refer to the Paper Submission GUIDE
before submitting your paper.
Selected Conference Papers
1) The Need for Including Hepatitis a Vaccine in Routine Childhood Immunization Programs in Europe as a Response to the Influx of Refugees from the Middle East and North Africa (MENA) RegionsS. Ramia, N. Melhem, K. Kreidieh 2) From Type-I to Type-II Fuzzy System Modeling for Diagnosis of HepatitisShahabeddin Sotudian, M. H. Fazel Zarandi, I. B. Turksen 3) A Medical Resource Forecasting Model for Emergency Room Patients with Acute HepatitisR. J. Kuo, W. C. Cheng, W. C. Lien, T. J. Yang 4) Profile of Viral Hepatitis in Saudi ArabiaA. A. Alshabanat, R. B. Albacker, A. A. Basalama, A. A. Bin Salamah, A. S. Alfrayh 5) Impact of Hepatitis C Virus Chronic Infection on Quality of Life in EgyptAmmal M. Metwally, Ghada A. Abdel-Latif, Walaa A. Fouad, Thanaa M. Rabah, Amira Mohsen, Fatma A. Shaaban, Iman I. Salama 6) Level of Behavioral Development for Hepatitis C Virus Cases versus Their Contacts: Does Infection Make a Difference and What Is Beyond?Ammal M. Metwally, Lobna A. El Etreby, Rehan M. Saleh, Ghada Abdrabou, Somia I. Salama, Amira Orabi, Mohamed Abdelrahman 7) Characterization of Liver Leukocyte Infiltrates and Features of Cytokine Profile under Viral Hepatitis-Induced ImmunosuppressionOlga V. Lebedinskaya, Irina N. Kabanovskaya, Anna S. Lasareva, Nelly K. Akhmatova, Anatoliy P. Godovalov, Andrey V. Horinko, Mikhail V. Kiselevsky 8) Sensitivity Comparison between Rapid Immuno-Chromatographic Device Test and ELISA in Detection and Sero-Prevalence of HBsAg and Anti-HCV antibodies in Apparently Healthy Blood Donors of Lahore, PakistanNatasha Hussain, Maleeha Aslam, Robina Farooq 9) The Prevalence of Transfusion-Transmitted Virus (TTV) Infection inIranian Patients with Chronic Hepatitis BP. Ghasemi Dehkordi, A. Doosti, M. R. Hajimirzaei 10) A Study of Liver Checkup in Patients with Hepatitis C in the Region of BatnaA. Zidani, M. Yahia K. Belhadi, S. Benbia 11) Artificial Intelligence Support for Interferon Treatment Decision in Chronic Hepatitis BAlexandru George Floares
Similar conferences about Medical and Health Sciences